PRIORITY (Enpowering Progression Risk of Cerebral Amyloid Angiopathy)
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
Objective: PRIORITY is a prospective observational study aimed at identifying clinical, neuroradiological, and biochemical biomarkers that could improve early diagnosis, risk stratification, and the identification of personalized therapeutic targets for CAA.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• patients of either sex over 18 years of age;
• patients with possible and probable symptomatic or asymptomatic CAA with or without histological demonstration (modified Boston criteria);
• patients who have had at least one brain MRI.
Locations
Other Locations
Italy
Fondazione IRCCS Istituto Neurologico Carlo Besta
RECRUITING
Milan
Contact Information
Primary
Anna Bersano, MD
anna.bersano@istituto-besta.it
+ 39 02.23941
Time Frame
Start Date: 2021-11-01
Estimated Completion Date: 2025-09
Participants
Target number of participants: 200
Related Therapeutic Areas
Sponsors
Leads: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta